Vivimed Labs Limited (VIVIMEDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Vivimed Labs Limited (VIVIMEDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vivimed Labs Limited (VIVIMEDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Vivimed Labs Limited (VIVIMEDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
25 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Vivimed Labs Limited (Vivimed) is a pharmaceutical company that manufactures active pharmaceutical ingredients used in home and personal care products. The company offers oral care products, reversacol photochromic dyes, sun care products, skin care and hair care products, anti-microbials and preservatives, imaging chemicals and nisarg. It manufactures photochromic dyes used in eyewear; and photographic chemicals used in traditional photographic imaging technology such as medical and industrial X-ray imaging, consumer photography and litho-plate production for the graphic arts industry. The company has presence in China, India, the UK and the US.

Vivimed Labs Limited (VIVIMEDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
-

  
Source:
Document ID
GDPH222072D
Country
Industry
Ticker
VIVIMEDLAB=I
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Vivimed Labs Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Vivimed Labs Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Vivimed Labs Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Vivimed Labs Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Vivimed Labs Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Vivimed Labs Limited, Pharmaceuticals &Healthcare, Deal Details1012
  Asset Purchase101
    Vivimed Labs Acquires Solid Oral Dosage Facility From Actavis Pharma For US$20 Million101
  Private Equity111
    Kitara Capital to Acquire Additional Stake in Vivimed Labs for USD2.6 Million111
    NYLIM Jacob And Kitara Invest US$27.5 Million In Vivimed Labs122
  Partnerships141
    CritiTech Enters Into Joint Venture With Finoso Pharma141
    UQUIFA Forms Joint Venture With Synthetics International151
  Debt Offering161
    Vivimed Labs Completes Private Placement Of Foreign Currency Convertible Bonds For US$7.5 Million161
  Acquisition171
    Vivimed Labs Acquires Finoso Pharma For US$3 Million171
    Vivimed Completes Acquisition Of Uquifa For US$55 Million182
    Vivimed Labs Acquires Ophthalmology Company Klar Sehen201
    Vivimed Labs Acquires 60% Stake In Octtantis Nobel Labs211
Vivimed Labs Limited - Key Competitors221
Key Employees231
Locations And Subsidiaries241
  Head Office241
  Other Locations &Subsidiaries241
Appendix251
  Methodology251
  About GlobalData251
  Contact Us251
  Disclaimer251

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Vivimed Labs Limited (VIVIMEDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Vivimed-Labs-Limited-VIVIMEDLAB-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7829>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Vivimed Labs Limited (VIVIMEDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Vivimed-Labs-Limited-VIVIMEDLAB-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7829>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research